Found: 53
Select item for more details and to access through your institution.
NOTCH gene alterations in metastatic colorectal cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 10, p. 2841, doi. 10.1007/s00432-022-04064-4
- By:
- Publication type:
- Article
Multiple synchronous early gastric carcinoma with seven lesions.
- Published in:
- 2003
- By:
- Publication type:
- Letter
Granular cell tumor occurring in the sigmoid colon treated by endoscopic mucosal resection using a transparent cap (EMR-C).
- Published in:
- Journal of Gastroenterology, 2003, v. 38, n. 4, p. 385, doi. 10.1007/s005350300068
- By:
- Publication type:
- Article
Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged >75 years.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 7, p. 717, doi. 10.1093/jjco/hyac073
- By:
- Publication type:
- Article
Severe Gastrointestinal Disorder Due to Capecitabine Associated with Dihydropyrimidine Dehydrogenase Deficiency: A Case Report and Literature Review.
- Published in:
- Internal Medicine, 2022, v. 61, n. 16, p. 2449, doi. 10.2169/internalmedicine.8636-21
- By:
- Publication type:
- Article
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1450, doi. 10.1007/s10147-022-02208-7
- By:
- Publication type:
- Article
Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study).
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 4, p. 684, doi. 10.1007/s10147-022-02114-y
- By:
- Publication type:
- Article
Retrospective analysis of neoadjuvant chemotherapy followed by surgery versus definitive chemoradiotherapy with proton beam for locally advanced esophageal squamous cell carcinoma.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 10, p. 1856, doi. 10.1007/s10147-021-01981-1
- By:
- Publication type:
- Article
Retrospective analysis for the efficacy and safety of nivolumab in advanced gastric cancer patients according to ascites burden.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 2, p. 370, doi. 10.1007/s10147-020-01810-x
- By:
- Publication type:
- Article
Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 4, p. 614, doi. 10.1007/s10147-019-01600-0
- By:
- Publication type:
- Article
Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER).
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1214, doi. 10.1007/s10147-019-01465-3
- By:
- Publication type:
- Article
A phase II study of 5-fluorouracil/L-leucovorin/oxaliplatin (mFOLFOX6) in Japanese patients with metastatic or unresectable small bowel adenocarcinoma.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 5, p. 905, doi. 10.1007/s10147-017-1138-6
- By:
- Publication type:
- Article
Phase II study of first-line chemotherapy with uracil-tegafur plus oral leucovorin in elderly (≥75 years) Japanese patients with metastatic colorectal cancer: SGOSG-CR0501 study.
- Published in:
- International Journal of Clinical Oncology, 2015, v. 20, n. 1, p. 111, doi. 10.1007/s10147-014-0675-5
- By:
- Publication type:
- Article
Optimal Maintenance Strategy for First-Line Oxaliplatin-Containing Therapy with or without Bevacizumab in Patients with Metastatic Colorectal Cancer: A Meta-Analysis.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 3, p. 703, doi. 10.4143/crt.2020.805
- By:
- Publication type:
- Article
Panitumumab-Induced Interstitial Lung Disease in a Case of Metastatic Colorectal Cancer.
- Published in:
- Oncology Research & Treatment, 2013, v. 36, n. 4, p. 209, doi. 10.1159/000349959
- By:
- Publication type:
- Article
Ovarian metastases from ileum cancer in a patient with germline EPCAM gene deletion successfully treated with surgical resection and CAPOX chemotherapy: a case report.
- Published in:
- BMC Medical Genetics, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s12881-020-01013-1
- By:
- Publication type:
- Article
A randomized, double‐blind, phase II study of oral histone deacetylase inhibitor resminostat plus S‐1 versus placebo plus S‐1 in biliary tract cancers previously treated with gemcitabine plus platinum‐based chemotherapy.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 6, p. 2088, doi. 10.1002/cam4.3813
- By:
- Publication type:
- Article
Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS)
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.576036
- By:
- Publication type:
- Article
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Fisher syndrome as an immune-related adverse event after using pembrolizumab but not nivolumab.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Relationship Between Thymidine Kinase 1 Expression and Trifluridine/Tipiracil Therapy in Refractory Metastatic Colorectal Cancer: A Pooled Analysis of 2 Randomized Clinical Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLUE] Study).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Anal canal adenocarcinoma with neuroendocrine features accompanying secondary extramammary Paget disease, successfully treated with modified FOLFOX6: a case report.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effect of massive ascites on ramucirumab pharmacokinetics in patients with gastrointestinal cancers: a population pharmacokinetic analysis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 4, p. 271, doi. 10.1007/s00280-023-04568-x
- By:
- Publication type:
- Article
Distribution of therapeutic monoclonal antibodies into ascites in advanced gastric cancer patients with peritoneal metastasis: case reports and literature review.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A phase II study of S-1, oxaliplatin, oral leucovorin, and bevacizumab combination therapy (SOLA) in patients with unresectable metastatic colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 547, doi. 10.1007/s00280-015-2825-5
- By:
- Publication type:
- Article
A phase I study of doxifluridine combined with weekly paclitaxel for metastatic gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 2, p. 138, doi. 10.1007/s00280-004-0983-y
- By:
- Publication type:
- Article
Phase I study of gemcitabine, cisplatin, and S-1 combination therapy for patients with untreated advanced biliary tract cancer.
- Published in:
- Journal of Hepato -- Biliary -- Pancreatic Sciences, 2015, v. 22, n. 9, p. 669, doi. 10.1002/jhbp.255
- By:
- Publication type:
- Article
Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1603, doi. 10.1038/s41416-023-02189-y
- By:
- Publication type:
- Article
Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 467, doi. 10.1007/s10120-020-01131-y
- By:
- Publication type:
- Article
First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 792, doi. 10.1007/s10120-018-0797-y
- By:
- Publication type:
- Article
Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G).
- Published in:
- Gastric Cancer, 2018, v. 21, n. 1, p. 84, doi. 10.1007/s10120-017-0725-6
- By:
- Publication type:
- Article
Risk factors for submucosal and lymphovascular invasion in gastric cancer looking indicative for endoscopic submucosal dissection.
- Published in:
- Gastric Cancer, 2014, v. 17, n. 4, p. 692, doi. 10.1007/s10120-013-0323-1
- By:
- Publication type:
- Article
A randomized phase II study comparing S-1 plus weekly split-dose cisplatin with S-1 plus standard-dose cisplatin as first-line chemotherapy for advanced gastric cancer.
- Published in:
- Gastric Cancer, 2014, v. 17, n. 2, p. 354, doi. 10.1007/s10120-013-0284-4
- By:
- Publication type:
- Article
Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?
- Published in:
- 2016
- By:
- Publication type:
- commentary
Early Tumor Shrinkage and Depth of Response in the Second-Line Treatment for KRAS exon2 Wild-Type Metastatic Colorectal Cancer: An Exploratory Analysis of the Randomized Phase 2 Trial Comparing Panitumumab and Bevacizumab in Combination with FOLFIRI (WJOG6210G)
- Published in:
- Targeted Oncology, 2020, v. 15, n. 5, p. 623, doi. 10.1007/s11523-020-00750-w
- By:
- Publication type:
- Article
High Orotate Phosphoribosyltransferase Gene Expression Predicts Complete Response to Chemoradiotherapy in Patients with Squamous Cell Carcinoma of the Esophagus.
- Published in:
- Oncology, 2009, v. 76, n. 5, p. 342, doi. 10.1159/000209964
- By:
- Publication type:
- Article
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin‐ or Irinotecan‐Based Chemotherapy in Patients with Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 327, doi. 10.1634/theoncologist.2018-0119
- By:
- Publication type:
- Article
Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study.
- Published in:
- Oncologist, 2018, v. 23, n. 1, p. 7, doi. 10.1634/theoncologist.2017-0275
- By:
- Publication type:
- Article
Enhanced G1 arrest and apoptosis via MDM4/MDM2 double knockdown and MEK inhibition in wild-type TP53 colon and gastric cancer cells with aberrant KRAS signaling.
- Published in:
- Oncology Letters, 2021, v. 22, n. 1, p. N.PAG, doi. 10.3892/ol.2021.12819
- By:
- Publication type:
- Article
FMS‐like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 1, p. 314, doi. 10.1111/cas.14693
- By:
- Publication type:
- Article
Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 11, p. 3565, doi. 10.1111/cas.14198
- By:
- Publication type:
- Article
Phase II trial of aflibercept with FOLFIRI as a second‐line treatment for Japanese patients with metastatic colorectal cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 1032, doi. 10.1111/cas.13943
- By:
- Publication type:
- Article
Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild-type KRAS colorectal cancer- WJOG 6210G.
- Published in:
- Cancer Science, 2016, v. 107, n. 12, p. 1843, doi. 10.1111/cas.13098
- By:
- Publication type:
- Article
Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin-3 in gastric cancer cells.
- Published in:
- Cancer Science, 2011, v. 102, n. 3, p. 605, doi. 10.1111/j.1349-7006.2010.01821.x
- By:
- Publication type:
- Article
Renal impairment as a risk factor for trifluridine/tipiracil-induced adverse events in metastatic colorectal cancer patients from the REGOTAS study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45244-7
- By:
- Publication type:
- Article